SAN FRANCISCO--(BUSINESS WIRE)--Millions of women around the world who do not have access to Pap test screening for cervical cancer could benefit from a non-invasive test that scans the cervix with light, according to results of a clinical trial presented at the American Society for Colposcopy and Cervical Pathology (ASCCP) biennial meeting, being held March 14-17 at the Hyatt Regency in San Francisco, California.
